Search results
Aug 5, 2022 · These included clarifying the distinction between “hyperbilirubinemia risk factors,” which increase the risk of subsequent hyperbilirubinemia, and “hyperbilirubinemia neurotoxicity risk factors,” which increase the risk of bilirubin neurotoxicity.
Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation. Features. Neurotoxicity risk factors absent, present, or both. Plot multiple time points to assess trends.
Sep 1, 2022 · Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022 Sep 1;150 (3):e2022058859. doi: 10.1542/peds.2022-058859. Authors.
In August 2022, the Academy released updated clinical guidance on the prevention and treatment of hyperbilirubinemia in newborns greater than 35 weeks of gestational age. This clinical practice guideline will remain valid for use in practice through August of 2027 and considered retired thereafter.
Nov 4, 2022 · The highly anticipated update to the American Academy of Pediatrics (AAP) Clinical Practice Guideline for management of hyperbilirubinemia in newborns ≥35 weeks gestation was published in August 2022.1 The revised guideline and accompanying technical report2 build on the prior recommendations with a decade and a half of new research.Several ...
AAP 2022 Hyperbilirubinemia Management Guidelines. Calculator and clinical decision support for the AAP 2022 guidelines for the management of hyperbilirubinemia in newborns 35 or more weeks of gestation.
The 2004 guideline made recommendations for primary prevention (eg, maternal Rh typing and treatment) and secondary prevention (eg, risk-factor assessment and close monitoring for the development of hyperbilirubinemia, and, when necessary, treatment).
Jan 10, 2024 · To help with implementation of the 2022 AAP guideline on the management of hyperbilirubinemia, two members of the authoring group, Alex Kemper and Thomas Newman, have put together this FAQ sheet.
Updated Clinical Practice Guidelines for Management of Hyperbilirubinemia in Infants Born at 35 Weeks or More Gestation. Pediatr Ann. 2023 Dec;52 (12):e436-e439. doi: 10.3928/19382359-20231016-07. Epub 2023 Dec 1. Author. Chandani DeZure. PMID: 38049191. DOI: 10.3928/19382359-20231016-07. Abstract.
Aug 5, 2022 · To update the evidence base necessary to develop the 2022 American Academy of Pediatrics clinical practice guideline for management of hyperbilirubinemia in the newborn infant ≥35 weeks’...
